Drug Research
US FDA grants emergency use authorization to Quanterixs Simoa SARS-CoV-2 N protein antigen test
Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its Simoa SARS-CoV-2 N Protein Antigen Test that can...
Drug Research
Abzena announces opening of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors
Abzena, a Global Partner Research Organization for integrated bench to market solutions for biologics and bioconjugates, has announced the addition of a 6th Global site that will augment cGMP manufacturing capacity for mammalian biologics. This expansion is driven by...
Drug Research
Baxter BioPharma Solutions Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine
Baxter International Inc., a global leader in sterile medication production and delivery, announced that Baxter BioPharma Solutions has entered into an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax’ COVID-19 recombinant nanoparticle vaccine candidate with Matrix-M™ adjuvant. Baxter...
Drug Research
FUJIFILM Diosynth Biotechnologies Begins Production of Two COVID-19 Vaccines Candidates at Texas Facility
FUJIFILM Diosynth Biotechnologies and the Texas A&M University System Center for Innovation in Advanced Development & Manufacturing (CIADM) announced that production has begun in Texas on two different COVID-19 vaccine candidates with support from the U.S. government to meet...
Drug Research
CEVEC Pharma grants Biogen rights to its proprietary Elevecta Technology for manufacturing of gene therapy products
CEVEC Pharmaceuticals GmbH announced the signing of a license agreement with Biogen Inc. for the use of CEVEC’s proprietary ELEVECTA® Technology for the manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications.
Under the terms of the agreement, CEVEC...
Drug Research
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors
Kite, a Gilead Company, and Oxford BioTherapeutics Ltd. (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (IO) and antibody-drug conjugate (ADC)-based therapies, announced that the companies have entered into a research collaboration to evaluate five novel...
Drug Research
Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases
Servier, a global pharmaceutical Group and X-Chem, Inc., a privately held drug discovery company announced a partnership to identify and develop novel small molecules for the treatment of neurological disorders.
Under the terms of the multi-target agreement, X-Chem will utilize...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
